November 2020

BHV Partners and Clave invest in MATCH biosystems

Clave and BHV Partners invest in MATCH biosystems, a biotechnology company that develops rapid pathogen detection tests in hospital and veterinary clinical settings. The objective of MATCH biosystems is the development of a manageable, low-cost, non-invasive test, capable of accurately detecting the pathogen identified as a clinical target in a few minutes. With current devices,…

Read article